Circulating heat shock proteins in women with a history of recurrent vulvovaginitis. by Giraldo, P C et al.
Infectious Diseases in Obstetrics and Gynecology 7:128-132 (1999)
(C) 1999 Wiley-Liss, Inc.
Circulating Heat Shock Proteins in Women With a
History of Recurrent Vulvovaginitis
P.C. Giraldo, 1,2. A.D. Ribeiro-Filho, 1 J.A. Simes, 1 A. Neuer,2
S.B.N. Feitosa, 1 and S.S. Witkin2
1Department of Gynecology and Obstetrics, University of Campinas, So Pau/o, Brazil
eDivision ofImmunology and Infectious Diseases, Department of Obstetrics and Gynecology, Cornell
University Medical College, New Yorb, NY
ABSTRACT
Objective: Predisposing factors influencingrecurrences of bacterial vaginosis (BV) or vaginitis from
Candida remain unidentified for most women. As a component of studies to determine host sus-
ceptibility factors to genital tractiiafeetions in women, we measured expression of the 60-kDa and
70-kDa heat shock proteins (hsp60 and hsp70, respectively) in the circulation of women with or
without a history of recurrent BV or candidal vaginitis and with or without a current lower genital
tract infection. Heat shock protein expression is associated with a down-regulation of pro-
inflammatory immune responses that would inhibit microbial infection.
Method: The investigators measured hsp60 and hsp70, antibodies to these proteins, the pro-
inflammatory cytokine tumor necrosis factor-a (TNF-a), and the anti-inflammatory cytokine in-
terleukin-10 (IL-10) in sera by ELISA. The study population consisted of 100 women who attended
a gynecology clinic in Campinas, Brazil. Of those, 55 had a history of recurrent vulvovaginitis
(RV), while 45 were controls with no such history. Only women who were asymptomatic for at
least 1 month were studied.
Results: Although all were asymptomatic, clinical and microbiological examination revealed that
five of the women with a history ofRV and two controls had a current candidal vaginal infection;
16 RV patients and 12 controls had BV; and six RV patients had both BV and candidiasis.
Twenty-eight RV patients and 31 controls had no clinical or microbiological detectable vaginal
infection. Among the RV patients, hsp60 and hsp70 were more prevalent in those with current BV
(40.9% and 50.0%, respectively) or a candidal infection (45.5% and 54.5%) than in women with no
current infection (21.4% and 17.9%). In the women with no history ofRV, BV was not associated
with a high prevalence of hsp60 (8.3%) or hsp70 (8.3%). Interleukin-10 and TNF were not more
prevalent in vaginitis patients or controls with a current candidal infection orBV than in uninfected
subjects.
Conclusion: The high prevalence of circulating hsp60 and hsp70 in women with a history ofRV
and current BV or vaginal candidiasis, but not in women with no history of RV, suggests that
differences in heat shock protein induction may be related to susceptibility to recurrent vaginal
infections. Infect. Dis. Obstet. Gynecol. 7:128-132, 1999. (C) 1999Wiley-Liss, Inc.
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requent recurrences of vaginitis caused by Can-
dida or bacterial vaginosis (BV) occur only in a
subgroup of women following an initial episode of
either infection. Why most women remain free of
symptoms for long periods after appropriate antibi-
otic treatment while the infections return shortly
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after cessation of therapy in others remains unex-
plained.
We have been examining host factors as deter-
minants of susceptibility to infections and their
consequence in the female genital tract. As a com-
ponent of these investigations the presence of the
60-kDa and 70-kDa heat shock proteins (hsp60 and
hsp70, respectively) in sera was determined. Hsp60
and hsp70 are highly conserved proteins present in
organisms ranging from bacteria to humans. Under
normal conditions, they function in die assembly,
folding, and transport of polypeptides. Synthesis of
both proteins is greatly accelerated under non-
physiological conditions to prevent incorrect pro-
tein aggregation or denaturation. Enhanced heat
shock protein expression is, thus, a sensitive indi-
cator of nonphysiological conditions.
Transcription of heat shock protein genes is also
coupled to the down-regulation of pro-inflam-
matory cytokine expression. Both interleukin
(IL-1) and tumor necrosis factor-or (TNF-ot) tran-
scription is inhibited by the stimulation of heat
shock protein gene activation,z-4 Since IL-1 and
TNF-ot are involved in initiation of immune re-
sponses, inhibition of their synthesis would impair
an organism’s immune defense. Therefore, expres-
sion of heat shock proteins might be associated
with diminished immunity and increased suscepti-
bility to infection.
In this communication we report on the high
prevalence of hsp60 and hsp70 in the circulation of
women with a history of recurrent vaginal infec-
tions (RV) and a current case of either candidal
infection or BV, but not in those currently free of
disease or in women with a current infection but no
history of recurrent vaginitis.
MATERIALS AND METHODS
Subjects
The study population consisted of 100 nonpreg-
nant, women of reproductive age who attended a
gynecology clinic in Campinas, Brazil. Fifty-five of
the women had at least three episodes of either
candidal vaginitis or BV in the past year, as deter-
mined from medical records. The diagnostic crite-
ria for these infections are stated below. The other
45 women had one or no vaginal infections in the
previous 12 months. The vaginal infections and
control groups were similar in age (30.09 + 7.9 years
in the infected group vs. 32.21 ___
7.7 years in the
control group), socioeconomic status, and racial
composition. In an effort to differentiate predispos-
ing factors from those associated with current clini-
cal infection, only subjects who were clinically
asymptomatic (no reports of itching, burning, dis-
charge, or soreness during intercourse) at the time
of sample collection and for at least month prior
were studied.
The study was approved by the Scientific and
Ethics Committee for Research at the University of
Campinas, Brazil.
Microbiological Diagnosis
The vaginal microbiology of each subject was as-
sessed by wet mount and Gram stain. Patients were
not menstruating and had not had intercourse for at
least 24 hours prior to the visit. Bacterial vaginosis
was diagnosed clinically by the presence of three of
the following: vaginal pH > 4.5, presence of a ho-
mogeneous grey/white discharge, detection of clue
cells, amine odor upon addition of potassium hy-
droxide to secretions. The presence of Candida was
assessed by wet mount, Gram stain, and culture in
Sabouraud medium.
Serum Samples
Blood was obtained by venipuncture, allowed to
clot, and sera was collected by centrifugation and
stored at -20C until shipped to New York on dry
ice for analysis.
Heat Shock Protein Detection
Hsp60 and hsp70 were detected in sera by ELISA
as describeds-7 utilizing specific monoclonal anti-
bodies bound to wells of a microtiter plate as the
capture antibody and polyclonal antibody as de-
tecting antibody (StressGen, Victoria, British Co-
lumbia). The values were converted to pg/mL by
reference to a standard curve generated with puri-
fied recombinant hsp60 and hsp70 (StressGen).
The lower limit of sensitivity was 10 ng/mL for
both proteins.
Antibodies to Heat Shock Proteins
Circulating immunoglobulin G (IgG) antibodies to
hsp60 and hsp70 were detected by ELISA as pre-
viously described8,9 using purified recombinant
hsp60 and hsp70 (StressGen) bound to wells of a
microtiter plate. Known positive and negative sera
were always assayed in parallel to the test samples.
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TABLE I. Vaginal infections in study subjects
Infection
Number of subjects (%)
History of No history
recurrent of recurrent
vaginal vaginal
infections infections
Candida 5 (9. I) 2 (4.4)
Bacterial vaginosis (BV) 16 (29. I) 12 (26.7)
Candida plus BV 6 (10.9) 0
None 28 (50.9) 31 (68.9)
aCandida was detected by wet mount, Gram stain, and culture.
bBV was detected by clinical criteria.
A sample was defined as positive for IgG antibod-
ies if it yielded an absorbance more than two stan-
dard deviations above the mean value obtained
with a panel of negative control sera.
Cytokine Detection
The presence of interleukin-10 (IL-10) and
TNF-a in sera was measured by commercial
ELISA (BioSource, Canarillo, CA). The value were
converted to pg]mL by reference to a standard
curve generated with purified cytokines. The
lower limit of sensitivity was 10 pg/mL.
Statistics
Fisher exact test was used to analyze differences
between groups in heat shock protein and cytokine
expression. Spearman rank correlation test was
used to analyze the relation between different as-
says.
RESULTS
Vaginal Infections
Although all subjects were asymptomatic for at
least the previous 30 days, they were not all free
from vaginal infections (Table 1). Bacterial vagino-
sis was identified in 16 (29.1%) of the RV patients
and 12 (26.7%) controls; five (9.1%) RV patients
and two (4.4%) controls had vaginal candidiasis,
while an additional six (10.9%) RV patients and no
controls had both BV and candidiasis. No infec-
tions were evident in 28 (50.9%) RV patients and in
31 (68.9%) controls. None of the differences be-
tween RV patients and controls were statistically
significant.
Heat Shock Protein Detection
Among the 55 women with a history of RV, 19
(34.5%) were seropositive for hsp70 (Table 1)
TABLE 2. Hsp60 and hsp70 in sera of women with
a history of recurrent vaginal infections
Current No. positive (%)
infection No. subjects hsp60 hsp70
None 28 6 (21.4) 5 (I 7.9)
Candida II 5 (45.5) 6 (54.5)
BV 22 9 (40.9) II (50.0)
aBV, bacterial vaginosis.
bsix women were positive for both Candida and BV.
cp 0.04 vs. no infection.
dp 0.03 VS. no infection.
Those with current BV or candidiasis had a higher
percentage of positive sera (50.0% and 54.5%, re-
spectively) than did women with no current infec-
tion (17.9%). The individual values are shown in
Fig. 1.
Similarly, 17 (30.9%) of the RV patients were
seropositive for hsp60 antigen. However, the RV
subjects with current BV or current candidiasis had
a higher percentage of hsp60-positive sera (40.9%
and 45.5%, respectively) than did women with a
past history of RV but with no current infection
(21.4%) (Table 2, Fig. 1).
In marked contrast, among the women with no
history of RV but with current BV, only one (8.3%)
was positive for hsp60 (P < 0.05 vs. RV group with
current BV) and only one (8.3%) was positive for
hsp70 (P < 0.05). Only two women in the control
group had current candidiasis; neither was hsp60-
positive, and one was hsp70-positive. There was no
difference in heat shock protein expression be-
tween RV patients and controls with no current
infection.
There was no relation between hsp60 or hsp70
and method of contraception or history of sexually
transmitted diseases. In both the control and RV
groups the presence of hsp60 and hsp70 were
highly correlated (P < 0.0001).
Cytokine Analysis
Among the women with a history of RV, IL-10 was
present in one (9.1%) with current candidiasis,
eight (36.4%) women with BV, and five (17.9%) of
those with no current vaginal infection. Among the
control women, four (33.3%) with current BV were
IL-10-positive, as were 12 women (38.7%) with no
current infection. None of these differences were
statistically significant.
Similarly, TNF-c was unrelated to current in-
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Fig. I. Circulating heat shock proteins in women with a history of recurrent vaginal infections, with or without a current
vaginal infection. Sera from 55 women with current candidal infection or BV were tested for hsp60 and hsp70 by ELISA. Values
were converted to IJg/mL by reference to a standard curve. Six women were positive for both Candida and BV. The horizontal
line indicates the mean value.
fection in women with past RV. Tumor necrosis
factor-or was detected in 18.2% of those with cur-
rent candidiasis, 22.7% of those with current BV,
and 21.4% of women with no current infection.
Among the controls, 25% of women with BV and
6.5% with no current infection were positive for
TNF-ot. All cytokine results are presented in Ta-
ble 3.
Antibodies to Heat Shock Proteins
The IgG antibodies to hsp60 were identified in
nine (16.6%) women with past RV and in six
(13.3%) controls. Similarly, IgG anti-hsp70 was pre-
sent in eight (14.5%) RV patients and in three
(6.7%) controls. In contrast to the heat shock pro-
tein antigen results, there were no differences be-
tween patients and controls, or between the pres-
ence or absence of a current infection, and heat
shock protein immunity.
DISCUSSION
In a previous smaller study, we demonstrated that
hsp60 and hsp70 were present in the vaginas of
asymptomatic women with a history of recurrent
candidal vaginitis or recurrent BV, but not in con-
trol women.7 The present investigation on a larger
TABLE 3. Cytokine production in relation to
current infection in women with or without a
history of recurrent candidal vaginitis or BV
Control Recurrent infection
Subjects IL-10 TNF-c IL-10 TNF-a
All
No. positive 17/45 5/45 13/55 1/55
Cytokines (pg/mL) 15-38 16-68 12-48 37-83
Current BV
No. positive 4/I 2 3/I 2 8/22 5/22
Cytokines (pg/mL) 28-38 17-68 12-46 33-105
Current Candida
No. positive I/2 0/2 I/I 2/I
Cytokines (pg/mL) 37 0 12 65-105
No current infection
No. positive 12/31 2/31 5/28 6/28
Cytokines (pg/rnL) 15-30 16-66 21-48 64-81
population confirms the association between heat
shock protein expression and history of RV and,
furthermore, reveals that the appearance of both
hsp60 and hspT0 in the circulation of those patients
corresponds to either a current candidal infection
or BV.
Heat shock protein expression was not associ-
ated with the presence of antibodies to hsp60 or
hsp70. This is consistent with previous studies on
the low incidence of circulating antibody to heat
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shock proteins in healthy women8 and suggests
that heat shock protein-related immunity is not a
risk factor for recurrences of vaginitis or BV.
The Hsp60 antigen previously has been dem-
onstrated in genital tract secretions from men with
sperm autoantibodies in association with Chlamydia
trachomatis infection.5 Similarly, hsp60 has been
identified in follicular fluids from infertile women
with chlamydial infection.1 The stress response
associated with a genital tract infection appears to
be sufficient to induce readily detectable levels of
heat shock proteins.
Heat shock protein expression in the vagina was
followed by the appearance of hsp60 and hsp70 in
the circulation. There is ample precedent for the
migration of substances from the vagina to the sys-
temic circulation. 11-13 The data are consistent with
the hypothesis that there are differences between
women with a history of RV and other women in
the inducibility or extent of induction of heat shock
protein expression following genital tract infection.
Studies to examine whether polymorphisms in heat
shock protein and immune regulatory genes in
these women are responsible for differences in
hsp60 and hsp70 gene expression are now in prog-
ress.
The relation between heat shock protein ex-
pression and the mechanism of recurrent candidal
vaginitis or BV remains to be determined. One pos-
sibility is that induction of heat shock protein gene
transcription is more readily induced in the vagina
in these patients than in other women and that the
concomitant inhibition of transcription of genes as-
sociated with induction of cellular immunity results
in a decreased ability to inhibit the growth of
pathogenic microorganisms in the vagina. The fail-
ure in the present study to detect differences in
serum TNF-c and IL-10 levels among groups sug-
gests that these samples might not be sufficiently
concentrated for accurate analysis. In an earlier
study, vaginal hsp60 and hsp70 was associated with
IL-10, an immunosuppressive cytokine. 7
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